DELAYNA HUNTER: Open Payments
NPI 1639591506 · KENNETT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 18 payments from 7 companies in 2025. Trend: 2023 $386 · 2024 $371 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $107 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| Viatris Specialty LLC | 2 | $38 |
| Lilly USA, LLC | 2 | $33 |
| Amgen Inc. | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: Ozempic, GEMTESA, YUPELRI, MOUNJARO, BREZTRI, OTEZLA, ROTATEQ, ZEPBOUND.
Industry payments across MO — which companies pay providers there.
